With substantial progress in developing its differentiated and innovative CGM and its significant market potential, Trinity Biotech’s board and management have determined that CGM technology and ...

Trinity Biotech (TRIB) announces the next stage in realizing its comprehensive transformation plan and development of its continuous glucose ...

Trinity Biotech PLC (NASDAQ:TRIB), a leading diagnostic substances company with a market capitalization of $13.12 million, has successfully amended and restated its credit and guaranty agreement, as ...

Trinity Biotech plc, a biotechnology company specializing in human diagnostics and diabetes management, announced it has secured an additional $4 million in debt financing from Perceptive Advisors.

Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor. Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company ...

医疗保健行业诊断产品开发商Trinity Biotech plc (TRIB)股价触及52周新低，达到0.72美元。根据InvestingPro数据显示，该公司目前背负着9370万美元的债务负担，过去十二个月的EBITDA为-865万美元。这一下跌反映出公司估值较此前出现显著收缩，标志着公司正处于充满挑战的 ...